WO2008110697A3 - Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles - Google Patents

Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles Download PDF

Info

Publication number
WO2008110697A3
WO2008110697A3 PCT/FR2008/000135 FR2008000135W WO2008110697A3 WO 2008110697 A3 WO2008110697 A3 WO 2008110697A3 FR 2008000135 W FR2008000135 W FR 2008000135W WO 2008110697 A3 WO2008110697 A3 WO 2008110697A3
Authority
WO
WIPO (PCT)
Prior art keywords
neurokinine
receptors
preventing
preparation
sexual dysfunction
Prior art date
Application number
PCT/FR2008/000135
Other languages
English (en)
Other versions
WO2008110697A2 (fr
Inventor
Lisa Arvanitis
Heritier Christiane L
Original Assignee
Sanofi Aventis
Lisa Arvanitis
Heritier Christiane L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38344897&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2008110697(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis, Lisa Arvanitis, Heritier Christiane L filed Critical Sanofi Aventis
Priority to JP2009548711A priority Critical patent/JP2010518052A/ja
Priority to EP08761838A priority patent/EP2131842A2/fr
Publication of WO2008110697A2 publication Critical patent/WO2008110697A2/fr
Publication of WO2008110697A3 publication Critical patent/WO2008110697A3/fr
Priority to US12/537,345 priority patent/US20100173879A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention a pour objet l'utilisation d'un composé antagoniste des récepteurs NK2 de la neuroquimine A pour la préparation de médicaments utiles pour la prévention et le traitement des dysfonctions sexuelles.
PCT/FR2008/000135 2007-02-07 2008-02-04 Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles WO2008110697A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2009548711A JP2010518052A (ja) 2007-02-07 2008-02-04 性機能障害の予防および治療に有用な薬物の調製のための、ニューロキニンａのｎｋ２受容体に対する化合物である拮抗薬の使用
EP08761838A EP2131842A2 (fr) 2007-02-07 2008-02-04 Utilisation d'un compose antagoniste des recepteurs nk-2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles
US12/537,345 US20100173879A1 (en) 2007-02-07 2009-08-07 Use of a compound antagonist to the nk2 receptors of neurokinin a for the preparation of drugs useful for preventing and treating of sexual dysfunction

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0700856 2007-02-07
FR0700856A FR2912058A1 (fr) 2007-02-07 2007-02-07 Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/537,345 Continuation US20100173879A1 (en) 2007-02-07 2009-08-07 Use of a compound antagonist to the nk2 receptors of neurokinin a for the preparation of drugs useful for preventing and treating of sexual dysfunction

Publications (2)

Publication Number Publication Date
WO2008110697A2 WO2008110697A2 (fr) 2008-09-18
WO2008110697A3 true WO2008110697A3 (fr) 2008-11-13

Family

ID=38344897

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/000135 WO2008110697A2 (fr) 2007-02-07 2008-02-04 Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles

Country Status (9)

Country Link
US (1) US20100173879A1 (fr)
EP (1) EP2131842A2 (fr)
JP (1) JP2010518052A (fr)
AR (1) AR065178A1 (fr)
CL (1) CL2008000383A1 (fr)
FR (1) FR2912058A1 (fr)
TW (1) TW200906406A (fr)
UY (1) UY30899A1 (fr)
WO (1) WO2008110697A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2653371T3 (da) 2012-04-17 2015-06-01 Bhbikes Europ S L Ramme med integreret batteri til pedal-assisteret cykel og fremgangsmåde til fremstilling af nævnte ramme

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792835A1 (fr) * 1999-04-27 2000-11-03 Sanofi Sa Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
FR2824828A1 (fr) * 2001-05-21 2002-11-22 Sanofi Synthelabo Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant
FR2873373A1 (fr) * 2004-07-23 2006-01-27 Sanofi Synthelabo Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
WO2006096435A1 (fr) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Compositions pharmaceutiques utiles dans le traitement et/ou la prevention de la depression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005286733B2 (en) * 2004-09-23 2009-11-05 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792835A1 (fr) * 1999-04-27 2000-11-03 Sanofi Sa Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
FR2824828A1 (fr) * 2001-05-21 2002-11-22 Sanofi Synthelabo Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant
FR2873373A1 (fr) * 2004-07-23 2006-01-27 Sanofi Synthelabo Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
WO2006096435A1 (fr) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Compositions pharmaceutiques utiles dans le traitement et/ou la prevention de la depression

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MEINHARDT W ET AL: "COMPARATIVE TOLERABILITY AND EFFICACY OF TREATMENTS FOR IMPOTENCE", 1999, DRUG SAFETY, ADIS PRESS, AUCKLAND, NZ, PAGE(S) 133-146, ISSN: 0114-5916, XP000853834 *

Also Published As

Publication number Publication date
TW200906406A (en) 2009-02-16
WO2008110697A2 (fr) 2008-09-18
JP2010518052A (ja) 2010-05-27
UY30899A1 (es) 2008-09-30
EP2131842A2 (fr) 2009-12-16
US20100173879A1 (en) 2010-07-08
AR065178A1 (es) 2009-05-20
CL2008000383A1 (es) 2008-07-04
FR2912058A1 (fr) 2008-08-08

Similar Documents

Publication Publication Date Title
SG163564A1 (en) Kinin antagonists for treating bladder dysfunction
HUE032897T2 (hu) Összeállítás férfi szexuális zavar kezelésére
WO2008021851A3 (fr) Nouveaux composés comme antagonistes ou agonistes inverses pour les récepteurs d'opioïdes
HK1149928A1 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors d2 nn-
WO2009137843A9 (fr) Antagonistes des récepteurs nmda utilisables pour le traitement de troubles neuropsychiatriques
WO2007128802A3 (fr) Utilisation de flibansérine pour le traitement des troubles de la libido post-ménopausiques
WO2009082038A3 (fr) Antagonistes des récepteurs ampa et zonisamide pour le traitement de l'épilepsie
GB2460597B (en) N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
WO2009140166A3 (fr) Dérivés d'oxazolobenzimidazole
WO2007136668A3 (fr) N-benzoyle et n-benzylpyrrolidin-3-ylamines comme antagonistes de l'histamine-3
MY160800A (en) 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
WO2012040636A3 (fr) Composés et méthodes de traitement de maladies à médiation par des récepteurs activés par une protéase
IL195514A0 (en) Substituted pyridiyl amide compounds as modulators of the histamine h3 receptor
WO2007141284A3 (fr) Antagonistes du peptide cgrp
SI2238110T1 (sl) Derivati 5,6-bisaril-2-piridin-karboksamida, njihova priprava in njihova terapevtska uporaba kot antagonisti receptorjev urotenzina II
CL2007003637A1 (es) Procedimiento para la preparacion de derivados benzimida piperacinilo y diazepanilo utiles para el tratamiento de trastornos y afecciones intermediadas por un receptor histamina.
WO2008045371A3 (fr) Azacyclylamines avec substitution n en tant qu'antagonistes de l'histamine-3
WO2007015157A3 (fr) Nouvelles utilisations de composes d'agonistes du recepteur de mc4
WO2007141530A3 (fr) Traitement de l'excès de production de sébum
WO2010077976A3 (fr) Antagoniste du récepteur de la prokinéticine et ses utilisations
WO2008088820A3 (fr) Antagonistes de récepteur de glutamate et procédés d'utilisation
WO2008079727A3 (fr) Compositions contenant un agoniste du récepteur adrénergique pan-alpha-2 et un anticonvulsif, destinées à traiter la douleur chronique
SI2001456T1 (sl) Uporaba zmesi, ki vsebuje antagonist na opioidnem kapa receptorju za zdravljenje disocialnih bolezni
WO2006106358A3 (fr) Utilisation d'antagonistes des recepteurs nk-3 dans le traitement de la nausee et des vomissements
WO2008075162A3 (fr) Composés pour le traitement d'un dysfonctionnement sexuel

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08761838

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008761838

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2009548711

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE